Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Santander – page 38

599 clinical trials in Santander, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Santander at a glance
599
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

599 trials in Santander

Open in trial search

Plasma cell myeloma

Not recruiting

Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bortezomib
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Renal transplant+1

Not recruiting

Study of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Vaestra Goetalandsregionen

Study on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Aerovate Therapeutics Inc.

Nephrotic syndrome

Not recruiting

Study on the Effectiveness and Safety of Obinutuzumab and Mycophenolate Mofetil in Children with Idiopathic Nephrotic Syndrome

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Obinutuzumab
  • Sponsor:F. Hoffmann-La Roche AG

Study Comparing Loncastuximab Tesirine and Rituximab with Standard Treatment for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:ADC Therapeutics SA

Cervix carcinoma

Not recruiting

Study of Dostarlimab for Patients with High-Risk Locally Advanced Cervical Cancer After Chemo-Radiation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer Ginecologico

Study on GSK4532990 for Adults with Nonalcoholic Steatohepatitis (NASH)

Investigational
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Gsk4532990A
  • Sponsor:Glaxosmithkline Research & Development Limited

Study on Nivolumab and Ipilimumab for Patients with Untreated Unresectable or Metastatic Urothelial Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study of RO7269162 in people at risk for or with early-stage Alzheimer's Disease: Effects on brain amyloid buildup

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Florbetaben (18F)
  • Sponsor:F. Hoffmann-La Roche AG

Long-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Imatinib
  • Sponsor:Aerovate Therapeutics Inc.

Asthma

Not recruiting

Study on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:Areteia Therapeutics Inc.

Study Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Santander

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on metastatic colorectal cancer, mantle cell lymphoma, and gastrointestinal cancers. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.

  • Colorectal Cancer Treatment Innovations
  • Lymphoma Therapy Advances
  • Gastric Cancer Interventions

Multiple studies exploring new therapeutic approaches for various cancer types, including melanoma and lung cancer.

02 Respiratory Medicine

Clinical trials investigating treatments for chronic rhinosinusitis and uncontrolled asthma. Research focuses on developing innovative therapies and improving patient quality of life.

  • Asthma Management
  • Nasal Polyps Treatment
  • Respiratory Disease Control

Studies evaluate both established and novel therapeutic approaches for respiratory conditions.

03 Autoimmune Disorders

Innovative research examining treatments for psoriatic arthritis and Sjögren's disease. Trials focus on evaluating new biological therapies and their effectiveness in managing symptoms.

  • Arthritis Treatment Solutions
  • Autoimmune Disease Management
  • Biological Therapy Assessment

Comprehensive studies targeting various manifestations of autoimmune conditions.

04 Neurological Studies

Research investigating treatments for Alzheimer's disease and its connection with Down syndrome. Studies also include trials for multiple sclerosis and related neurological conditions.

  • Alzheimer's Disease Research
  • Multiple Sclerosis Treatments
  • Neurological Disease Management

Focused on developing effective treatments for complex neurological disorders.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.